INDO US BIOTECH
Back to Income Statement
|
INDO US BIOTECH Last 5 Year Total Expenditure History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹85 Cr | ₹62 Cr | ₹52 Cr | ₹43 Cr | ₹35 Cr |
What is the latest Total Expenditure of INDO US BIOTECH ?
| Year | Total Expenditure |
|---|---|
| Mar2025 | ₹85 Cr |
| Mar2024 | ₹62 Cr |
| Mar2023 | ₹52 Cr |
| Mar2022 | ₹43 Cr |
| Mar2021 | ₹35 Cr |
How is Total Expenditure of INDO US BIOTECH Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2025 | ₹85 Cr | 36.87 | |
| Mar2024 | ₹62 Cr | 18.49 | |
| Mar2023 | ₹52 Cr | 21.40 | |
| Mar2022 | ₹43 Cr | 24.73 | |
| Mar2021 | ₹35 Cr | - | |
Compare Total Expenditure of peers of INDO US BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDO US BIOTECH | ₹234.4 Cr | -6.2% | -17.3% | -50.9% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹12,982.8 Cr | -8% | -11.5% | -27.4% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,889.8 Cr | -10.7% | -10.2% | 22% | Stock Analytics | |
| VENKYS (INDIA) | ₹1,884.3 Cr | -0% | -8.7% | -22.7% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹1,179.2 Cr | -1.2% | -9.9% | -24.9% | Stock Analytics | |
| MANGALAM GLOBAL ENTERPRISE | ₹485.1 Cr | -1.9% | -3% | 31.1% | Stock Analytics | |
INDO US BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDO US BIOTECH | -6.2% |
-17.3% |
-50.9% |
| SENSEX | -0.1% |
0.6% |
9.8% |
You may also like the below Video Courses